The substantiation of the composition of an extemporaneous cream with antipsoriatic and anti-inflammatory effects
DOI:
https://doi.org/10.24959/nphj.25.178Keywords:
composition; naphthalаn oil; purified naphthalan oil; excipients; soft dosage forms; cream; antipsoriatic effect; anti-inflammatory effectAbstract
Aim. To substantiate an extemporaneous emulsion cream based on purified naphthalan oil for the pharmacotherapy of psoriasis.
Materials and methods. Such methods as system analysis and generalization, as well as organoleptic, physicochemical, structural-mechanical, biopharmaceutical and statistical methods were used in the work.
Results. The composition of an extemporaneous agent in the form of a cream for external use with the antipsoriatic and anti-inflammatory action were substantiated. It contains a purified naphthalan oil, the chamomile oil extract and a 10 % oil solution of vitamin A as active components of the substance of natural origin. Six model samples of the emulsion cream were processed; Tween-80, emulsifier No. 1 and Olivem 1000 were introduced in them as emulsifiers. Glycerol and propylene glycol in the concentration of 10 % were used as structure-forming substances of the hydrophilic phase. Colloidal and thermal stability, pH, structural viscosity and kinetics of the active component release were determined by the agar diffusion method in order to substantiate the excipients in the composition of the emulsion cream.
Conclusions. As a result of the organoleptic, physicochemical, structural-mechanical and biopharmaceutical studies conducted, the composition of an extemporaneous emulsion cream with antipsoriatic and anti-inflammatory effects based on white purified naphthalan oil has been experimentally substantiated.
References
Flohr, C., & Hay, R. (2021). Putting the burden of skin diseases on the global map. Br. J. Dermatol, 184, 189-190.
Nutten, S. (2015). Atopic dermatitis: global epidemiology and risk factors. Ann. Nutr. Metab, 66, 8-16.
Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E., & Barker, J. (2021). Psoriasis. Lancet, 397, 1301-1315.
Schleicher, S. M. (2016). Psoriasis: Pathogenesis, Assessment, and Therapeutic Update. Clin Podiatr Med Surg, 33 (3), 355-366.
Ogawa, E., Sato, Y., Minagawa, A., & Okuyama, R. (2018). Pathogenesis of psoriasis and development of treatment. J Dermatol, 45 (3), 264-272.
An, P., Zhao, Q., Hao, S., Wang, X., Tian, J., & Ma, Z. (2024). Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis. Int. J. Nanomed, 19, 7631-7671.
Kovalenko, V. M. (Red.). (2021). Kompendium 2021. Likarski preparaty Ukrainy. https://compendium.com.ua/.
Derzhavnyi reiestr likarskykh zasobiv Ukrainy. http://www. drlz.kiev.ua.
Farmatsevtychna entsyklopediia. http://www.pharmencyclopedia.com.ua.
Williams, D. M. (2018). Clinical Pharmacology of Corticosteroids. Respir. Care, 63, 655-670.
Samborskyi, O. S. (2018). Doslidzhennia mozhlyvostei ekstemporalnoho vyhotovlennia v Ukraini ta za kordonom. Farmatsevtychnyi chasopys,1, 102-114.
Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv». (2018, 2020). Derzhavna Farmakopeia Ukrainy. (2-he vyd.). (dopov. 2, 4).
Derzhspozhyvstandart Ukrainy. (2009). Kremy kosmetychni. Zahalni tekhnichni umovy (DSTU 4765:2007).
Abbasov, V. M., Isayeva, G. A., Aliyev, F. Sh., Nabiyeva, N. D., Movsumova, P. A., & Ismayilova, G. E. (2024). Analysis of Scientific Results on the Study of Therapeutic Naftalan Oil. PPOR, 25(4), 953-984.
Adigozalova, V. (2023). Naftalan oil is a specific balneological factor of Azerbaijan. Azerbaijan Journal of Physiology, 38, 48-56.
Zaichenko, H. V., & Horbach, A. O. (2023). Vyvchennia protyzapalnoi aktyvnosti kremiv iz riznoiu kontsentratsiieiu ochyshchenoho naftalanovoho masla na modeli karahinanovoho nabriaku v shchuriv. In Farmatsevtychna osvita, nauka ta praktyka: stan, problemy, perspektyvy rozvytku (s. 34-36). Nats. med. un-t imeni O. O. Bohomoltsia.
Martynova, G. S., Nanajanova, R. G., Velimetova, N. I., Zeinalov, S. Q., Babayeva, N. I., & Muradkhanova, L. R. (2022). On some aspects of naftalan oil properties. Chemical Problems, 2(20), 122-132.
Zaychenko, G., Gorchakova, N., Horbach, A., Stan, I., & Simonov, P. (2024). Theoretical and experimental justification of development of dermatological medicinal products based on natural compounds of naftalan oil. Fitoterapiia. Chasopys, 3, 52-61.
Honcharov, I., Vyshnevska, L., & Bodnar, L. (2024). Research on the development of solid soap composition for the prevention and treatment of psoriasis relapse. ScienceRise: Pharmaceutical Science, 5(51), 47-54.
Albayati, N., Talluri, S. R., Dholaria, N., & Michniak-Kohn, B. (2025). AI-Driven Innovation in Skin Kinetics for Transdermal Drug Delivery: Overcoming Barriers and Enhancing Precision. Pharmaceutics, 17(2), 188.
Smaliukh, O. H., & Sur, S. V. (2018). Otsinka skladu ta vmistu biolohichno aktyvnykh rechovyn kompleksnykh roslynnykh ekstraktiv, otrymanykh za riznomanitnymy tekhnolohiiamy. Farmatsevtychnyi chasopys, 4, 13-19.
Kolahdooz, S., Karimi, M., Esmaili, N., Zargaran, A., Kordafshari, G., Mozafari, N., & Ayati, M. H. (2018). Evaluation of the efficacy of a topical chamomile-pumpkin oleogel for the treatment of plaque psoriasis: an intra-patient, double-blind, randomized clinical trial. Biomedical Research and Therapy, 5, 2811-2819.
Williams, A. L., Pace, N. D., & DeSesso, J. M. (2020). Teratogen update: topical use and third-generation retinoids. Birth Defects Res, 112(15), 1105-1114.
Almuqbil, R. M., & Aldhubiab, B. (2025). Bioadhesive Nanoparticles in Topical Drug Delivery: Advances, Applications, and Potential for Skin Disorder Treatments. Pharmaceutics, 17(2), 229.
Yefimova, V., Pylypenko, T., Nikora, O., & Nevpriaha, P. (2018). Rozrobka retseptury emulsiinoho kosmetychnoho produktu na osnovi koloidnykh zakonomirnostei. Tekhnichni nauky ta tekhnolohii, 1(11), 178-187.
Ruban, O. A., Pertsev, I. M., Kutseko, S. A., & Maslii, Yu. S. (2016). Dopomizhni rechovyny u vyrobnytstvi likiv : navch. posib. dlia studentiv vyshch. farmats. navch. zakl. (I. M. Pertsev, Red.). Zoloti storinky.
Kovalova, T. M., Polovko, N. P. (2013). Fizyko-khimichne ta reolohichne doslidzhennia emulsiinykh osnov z kompleksnym emulhatorom Olivem 1000. Problemy ekolohichnoi ta medychnoi henetyky i klinichnoi imunolohii, 2, 222-229.
The United States Pharmacopeia: 30 – NF25. (2007). The United States Pharmacopeia, Inc.
Shmatenko, O., Pidlisny, O., Prykhodko, T., Solomennyi, A., Pritula, R., Semenchenko, G., Takhtaulova, N. (2020). Technological aspects of creating soft dosage forms for the treatment of purulent wounds. Ukrainian Journal of Military Medicine, 1(1), 50-63.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
